- Home
- HEPS vs OLMA Comparison
HEPS vs OLMA Comparison
Compare HEPS & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HEPS | OLMA |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | Turkey | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 949.3M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HEPS | OLMA |
|---|---|---|
| Price | $2.70 | $6.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 12 |
| Target Price | $3.31 | ★ $36.50 |
| AVG Volume (30 Days) | 380.7K | ★ 1.2M |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $34.24 | N/A |
| Revenue Next Year | $29.65 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.15 | $6.61 |
| 52 Week High | $3.30 | $36.26 |
Technical Indicators
Market Signals| Indicator | HEPS | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 56.18 | 17.35 |
| Support Level | $2.52 | N/A |
| Resistance Level | $2.78 | $11.27 |
| Average True Range (ATR) | 0.08 | 0.39 |
| MACD | 0.03 | -0.10 |
| Stochastic Oscillator | 79.49 | 2.97 |
Price Performance
Historical ComparisonAbout HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. It's portfolio offers its retail customers a wide selection of merchandise including electronics and non-electronics (including books, sports, toys, kids and baby products, cosmetics, furniture, etc). The Group derives revenue from the sales of goods, marketplace revenues and other revenues.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.